Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Loss of Nrf2 promotes rapid progression to heart failure following myocardial infarction.

Strom J, Chen QM.

Toxicol Appl Pharmacol. 2017 Jul 15;327:52-58. doi: 10.1016/j.taap.2017.03.025. Epub 2017 Apr 2.

PMID:
28373008
2.

Sodium Sulfide Attenuates Ischemic-Induced Heart Failure by Enhancing Proteasomal Function in an Nrf2-Dependent Manner.

Shimizu Y, Nicholson CK, Lambert JP, Barr LA, Kuek N, Herszenhaut D, Tan L, Murohara T, Hansen JM, Husain A, Naqvi N, Calvert JW.

Circ Heart Fail. 2016 Apr;9(4):e002368. doi: 10.1161/CIRCHEARTFAILURE.115.002368.

3.

Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction.

Bae S, Singh SS, Yu H, Lee JY, Cho BR, Kang PM.

J Appl Physiol (1985). 2013 Apr;114(8):979-87. doi: 10.1152/japplphysiol.01506.2012. Epub 2013 Feb 21.

4.

A new model of congestive heart failure in rats.

Chen J, Chemaly ER, Liang LF, LaRocca TJ, Yaniz-Galende E, Hajjar RJ.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H994-1003. doi: 10.1152/ajpheart.00245.2011. Epub 2011 Jun 17.

5.

Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death.

Lal H, Zhou J, Ahmad F, Zaka R, Vagnozzi RJ, Decaul M, Woodgett J, Gao E, Force T.

Circulation. 2012 Jan 3;125(1):65-75. doi: 10.1161/CIRCULATIONAHA.111.050666. Epub 2011 Nov 15.

7.

Wild-type p53-induced Phosphatase 1 Deficiency Exacerbates Myocardial Infarction-induced Ischemic Injury.

Liu KM, Zhang HH, Wang YN, Wang LM, Chen HY, Long CF, Zhang LF, Zhang HB, Yan HB.

Chin Med J (Engl). 2017 Jun 5;130(11):1333-1341. doi: 10.4103/0366-6999.206353.

8.

Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure.

Ahmad F, Lal H, Zhou J, Vagnozzi RJ, Yu JE, Shang X, Woodgett JR, Gao E, Force T.

J Am Coll Cardiol. 2014 Aug 19;64(7):696-706. doi: 10.1016/j.jacc.2014.04.068.

9.

MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.

van Rooij E, Doevendans PA, Crijns HJ, Heeneman S, Lips DJ, van Bilsen M, Williams RS, Olson EN, Bassel-Duby R, Rothermel BA, De Windt LJ.

Circ Res. 2004 Feb 20;94(3):e18-26. Epub 2004 Jan 22.

PMID:
14739160
10.

Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.

Most P, Seifert H, Gao E, Funakoshi H, Völkers M, Heierhorst J, Remppis A, Pleger ST, DeGeorge BR Jr, Eckhart AD, Feldman AM, Koch WJ.

Circulation. 2006 Sep 19;114(12):1258-68. Epub 2006 Sep 4.

PMID:
16952982
11.

Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.

Li GH, Shi Y, Chen Y, Sun M, Sader S, Maekawa Y, Arab S, Dawood F, Chen M, De Couto G, Liu Y, Fukuoka M, Yang S, Da Shi M, Kirshenbaum LA, McCulloch CA, Liu P.

Circ Res. 2009 Apr 10;104(7):896-904. doi: 10.1161/CIRCRESAHA.108.172882. Epub 2009 Feb 26.

PMID:
19246681
12.

Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.

Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T, Takahashi H, Arimoto T, Maeda K, Yamakawa M, Takeuchi O, Akira S, Takeishi Y, Kubota I.

Circulation. 2003 Dec 9;108(23):2905-10. Epub 2003 Dec 1.

PMID:
14656915
13.

Excessive sympathoactivation and deteriorated heart function after myocardial infarction in male ghrelin knockout mice.

Mao Y, Tokudome T, Otani K, Kishimoto I, Miyazato M, Kangawa K.

Endocrinology. 2013 May;154(5):1854-63. doi: 10.1210/en.2012-2132. Epub 2013 Mar 20.

PMID:
23515286
14.

Enhanced β-adrenergic cardiac reserve in Trpm4⁻/⁻ mice with ischaemic heart failure.

Jacobs G, Oosterlinck W, Dresselaers T, Geenens R, Kerselaers S, Himmelreich U, Herijgers P, Vennekens R.

Cardiovasc Res. 2015 Mar 1;105(3):330-9. doi: 10.1093/cvr/cvv009. Epub 2015 Jan 18.

PMID:
25600961
15.

Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction.

Kawano S, Kubota T, Monden Y, Tsutsumi T, Inoue T, Kawamura N, Tsutsui H, Sunagawa K.

Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1337-44. Epub 2006 Apr 21.

16.

Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction.

Takenaka H, Horiba M, Ishiguro H, Sumida A, Hojo M, Usui A, Akita T, Sakuma S, Ueda Y, Kodama I, Kadomatsu K.

Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H462-9. doi: 10.1152/ajpheart.00733.2008. Epub 2008 Dec 5.

17.

Left ventricular diastolic dysfunction in Nrf2 knock out mice is associated with cardiac hypertrophy, decreased expression of SERCA2a, and preserved endothelial function.

Erkens R, Kramer CM, Lückstädt W, Panknin C, Krause L, Weidenbach M, Dirzka J, Krenz T, Mergia E, Suvorava T, Kelm M, Cortese-Krott MM.

Free Radic Biol Med. 2015 Dec;89:906-17. doi: 10.1016/j.freeradbiomed.2015.10.409. Epub 2015 Oct 22.

18.

Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction.

Liu YH, Carretero OA, Cingolani OH, Liao TD, Sun Y, Xu J, Li LY, Pagano PJ, Yang JJ, Yang XP.

Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2616-23. Epub 2005 Jul 29.

19.

Direct Evidence that Myocardial Insulin Resistance following Myocardial Ischemia Contributes to Post-Ischemic Heart Failure.

Fu F, Zhao K, Li J, Xu J, Zhang Y, Liu C, Yang W, Gao C, Li J, Zhang H, Li Y, Cui Q, Wang H, Tao L, Wang J, Quon MJ, Gao F.

Sci Rep. 2015 Dec 14;5:17927. doi: 10.1038/srep17927.

20.

Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.

Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, Kubota T, Imanaka-Yoshida K, Itoh T, Takeshita A.

Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1229-35. Epub 2003 May 29.

Supplemental Content

Support Center